Columbia Laboratories to Present At UBS Warburg Annual Global Specialty Pharmaceuticals Conference.Business Editors/Health & Medical Writers NEW YORK--(BUSINESS WIRE)--May 22, 2001 Columbia Laboratories (AMEX AMEX See: American Stock Exchange :COB) today announced that Fred Wilkinson, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will be presenting on Wednesday, May 23, 2001 at 8:30 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT to the invited guests of UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Warburg at the 5th annual UBS Warburg Global Specialty Pharmaceuticals Conference in New York, NY. Listen-only telephone conference lines will be available for the public to hear the presentation. The live dial-in numbers are 888/515-2781 (domestic) and 719/457-2605 (international), and the replay numbers are 800/759-8603 (domestic) and 402/220-8537 (international). Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to research and development of women's health care and endocrinology products, including those intended to treat infertility, dysmenorrhea dysmenorrhea Pain or cramps before or during menstruation. In primary dysmenorrhea, caused by endocrine imbalances, severity varies widely. Irritability, fatigue, backache, or nausea may also occur. , endometriosis and hormonal deficiencies. Columbia is also developing hormonal products for men and a buccal delivery system for peptides. Columbia's products primarily utilize the company's patented bioadhesive delivery technology. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion